Cardiac Microcatheter Market Scope And Analysis

Report Code : TIPRE00029957
Category : Life Sciences

Status : Published
No. of Pages : 150

Buy Now

Cardiac Microcatheter Market Scope and Analysis Report by 2028

Buy Now

Cardiac Microcatheter Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 332.97 Million
Market Size by 2028	US$ 487.20 Million
Global CAGR (2022 - 2028)	6.8%
Historical Data	2020-2021
Forecast period	2023-2028
Segments Covered	By Indication General Peripheral Vascular and Coronary By End User Hospitals Specialty Clinics Ambulatory Surgical Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Boston Scientific Corp Teleflex Inc Medtronic Plc OrbusNeich Medical Group Holdings Ltd Asahi Intecc USA Inc Merit Medical Systems Inc Nipro Corp Terumo Corp Tokai Medical Products Inc

Key Player Analysis

Boston Scientific Corp, Teleflex Inc, Medtronic Plc, OrbusNeich Medical Group Holdings Ltd, Asahi Intecc USA Inc, Merit Medical Systems Inc, Nipro Corp, Terumo Corp, Tokai Medical Products Inc, and Integer Holdings Corp. are among the major players operating in the cardiac microcatheter market. Among these players, Medtronic Plc and Boston Scientific Corp are the top two players owing to the diversified product portfolio they offer.

Recent Developments

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the cardiac microcatheter market. A few recent key market developments are listed below:

In 2019, Navitian, a new coronary microcatheter from iVascular, received the CE mark approval. The device was approved to facilitate, guide, and support a guidewire while accessing the coronary system, exchanging guidewires, and injecting radiopaque contrast media or saline solutions.
In 2020, Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II Rapid Exchange fractional flow reserve (FFR) microcatheter, the second-generation microcatheter for use with its Acist RXi Rapid Exchange FFR System. FFR measurements assess arterial lesion severity and the intervention strategies in diagnosing and treating coronary artery disease.
In 2021, Baylis Medical unveiled the first clinical case of the JLL 2-French electrophysiology microcatheter in Europe. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, thereby introducing the smallest diagnostic catheter available in the European market. The 2F microcatheter also allows mapping and pacing in smaller anatomy, such as the Vein of Marshall.
In 2023, Al Qassimi Hospital in the UAE collaborated with Philips in order to allow access to Ultra-Low Contrast Percutaneous Coronary Intervention (ULC-PCI) to more patients in the Middle East, Turkey, and Africa. The new ULC-PCI Interventional Cardiology course at Al Qassimi Hospital is part of a global education program by Philips to share knowledge regarding the technology that can offer low-contrast, minimally invasive treatment for coronary artery disease, thereby spreading awareness among patients.